Concepedia

B. Szatmári

BS

Statistics

Publications

11

Citations

902

H-Index

11

Active since

2015

Affiliations

Gedeon Richter (Hungary)(Current)

Allergan (United States)

AbbVie (United States)

Northwell Health

Charité - Universitätsmedizin Berlin

B. Szatmári is an author at Gedeon Richter (Hungary) specializing in psychopharmacology, psychiatry, and schizophrenia pharmacotherapy.

Publications per year

2015–2022

11

Publications

11

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

György Németh, I. Laszlovszky, Pál Czobor et al. · The Lancet · 2017 · 352 citations

, , +14

Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study

Willie Earley, Maria Victoria Burgess, Ludmyla Rekeda et al. · American Journal of Psychiatry · 2019 · 155 citations · Full text

, , +17

The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors

Wolfgang Fleischhacker, Silvana Galderisi, I. Laszlovszky et al. · European Psychiatry · 2019 · 116 citations · Full text

, , +16

Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data

Willie Earley, Hua Guo, David G. Daniel et al. · Schizophrenia Research · 2018 · 68 citations · Full text

, , +17

Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia

Stefan Leucht, Ágota Barabássy, I. Laszlovszky et al. · Neuropsychopharmacology · 2019 · 52 citations · Full text

, , +17

1–5 of 11